School of Pharmacy

Raising the Smoking Age

Substantial Evidence in 21st Century Regulatory Science: Borrowing Strength from Accumulating Data

The statutory requirement for substantial evidence of effectiveness of a new drug has generally been interpreted to require demonstration of a low probability (p<0.05), assuming non-effectiveness, based on data from two phase III clinical trials.

UC San Francisco establishes Quantitative Biosciences Institute

UC San Francisco today announced the establishment of the Quantitative Biosciences Institute (QBI).

UCSF PharmD program ranked among the nation’s best

The UCSF School of Pharmacy’s doctor of pharmacy (PharmD) program is among the top-ranked programs in the 2017 U.S. News and World Report survey of accredited PharmD programs released on March 15, 2016.

Craik receives Protein Society’s Emil Thomas Kaiser Award

Charles S. Craik, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry, has been named the 2016 recipient of the Protein Society’s Emil Thomas Kaiser Award.

29th Annual Course on Pharmacokinetics for Pharmaceutical Scientists















A five-day fundamentals course emphasizing basic principles in pharmacokinetics. This is an annual course now in its 29th year.

Pages